Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma

Oral cavity squamous cell carcinoma (OCSCC) is a prevalent surgically treated subset of head and neck cancer with frequent recurrence and poor survival. Immunotherapy has demonstrated efficacy in recurrent/metastatic head and neck cancer. However, whether antitumor responses could be fostered by neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Knochelmann, Hannah M., Horton, Joshua D., Liu, Sixue, Armeson, Kent, Kaczmar, John M., Wyatt, Megan M., Richardson, Mary S., Lomeli, Shirley H., Xiong, Ying, Graboyes, Evan M., Lentsch, Eric J., Hornig, Joshua D., Skoner, Judith, Stalcup, Seth, Spampinato, Maria V., Garrett-Mayer, Elizabeth, O’Quinn, Elizabeth C., Timmers, Cynthia D., Romeo, Martin J., Wrangle, John M., Young, M. Rita I., Rubinstein, Mark P., Day, Terry A., Lo, Roger S., Paulos, Chrystal M., Neskey, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561313/
https://www.ncbi.nlm.nih.gov/pubmed/34755137
http://dx.doi.org/10.1016/j.xcrm.2021.100426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561313/
https://www.ncbi.nlm.nih.gov/pubmed/34755137
http://dx.doi.org/10.1016/j.xcrm.2021.100426

Ejemplares similares